![]() |
Canine Hereditary Spinal Muscular Atrophy |
![]() |
Hereditary Canine Spinal Muscular Atrophy (HCSMA) is a motor neuron disease that cause degeneration of motor neurons in the anterior (near the head) section of the spinal cord. Motor neurons are the nerve cells that convey impulses to the muscles to produce movement. This condition results in significant progressive muscular weakness and atrophy resulting in difficulty in supporting weight, reduced reflexes, abnormal gait, muscle tremors, and loss of muscle tone/mass (muscle atrophy). A subcategory of the condition called German Shepherd Focal Spinal Muscular Atrophy often seen in dogs of German Shepherd heritage is thought to involve a smaller area of motor neuron damage.
Once initial muscle weakness is observed, the condition generally becomes rapidly progressive. The condition is considered “accelerated” if initial weakness is noted prior to 1 month of age and progresses rapidly, “ intermediate” if initial weakness noted at 4‑6 months of age and progresses rapidly, and “chronic” if the initial weakness is noted in an older puppy and progresses slowly. Accelerated motor neuron disease generally results in paralysis before the age of six months, and intermediate motor neuron disease by 2-3 years of age. Dogs with the “chronic” form of motor neuron disease may live well into their adult lives. Similarly, the effects of focal spinal muscular atrophy often seen in breeds of German Shepherd heritage can be relatively mild and slow to progress. Additionally, unlike some other forms of motor neuron disease, the weakness or paralysis may be limited to the tail, hind end, or even just one limb.![]() |
Canine Hereditary Spinal Muscular Atrophyrelated terms: inherited motor neuron diseaseshttp://www.upei.ca/cidd |
| Abnormality | Breeds affected (RARE) | Inheritance | Clinical features |
| Spinal muscular atrophy | Brittany spaniel |
|
signs appear by 3 to 4 months (homozygotes), and are rapidly progressive; or not until 2 to 3 years (heterozygotes); initial weakness in hind end progresses to involve all 4 limbs |
| Focal spinal muscular atrophy | German shepherd | unknown | signs by 1 to 2 months; weakness in the front legs |
| Hereditary progressive spinal muscular atrophy | English pointer | AR | weakness in hind limbs by 6 months; progresses to forelimbs |
| Motor neuron disease | Rottweiler | unknown | signs
by 1 to 2 months; weakness in all limbs +/- abnormalities in swallowing
causing regurgitation (megaesophagus)
|
| Multisystemic
chromatolytic neuronal degeneration |
Cairn terrier | unknown | signs
by 4 to 7 months; generalized weakness, poor coordination, head tremor |
AR
(Autosomal recessive) This is the most
common mode of inheritance for genetic conditions in dogs. Progressive
retinal atrophy (PRA), which causes blindness in many breeds, is such a
trait. To be affected, the animal must inherit 2 copies of the gene
(genotype pp), 1 from each parent. Dogs with the genotype PP (normal)
or Pp (carrier) will be clinically normal but the carrier will pass the
affected gene to approximately half the offspring. As long as carriers
(Pp) are mated to normal animals (PP), the offspring will be unaffected
but some will remain carriers. If 2 carriers are mated, some of the
offspring (approximately 25%) will be affected.
How is spinal muscular atrophy
diagnosed?
Diagnosis is based on a thorough neurologic examination, the absence of
abnormalities on routine diagnostic tests, and the progressive nature
of these conditions. Specific diagnostic tests include muscle biopsy
and electronic testing of nerve conduction potentials (an
electromyogram) of affected muscles.
For the veterinarian: The lower
motor neuron signs with these disorders may be confused with canine
protozoan radiculomyelitis. Electromyography typically shows
spontaneous denervation potentials. Muscle atrophy is evident on muscle
biopsy.
How is spinal muscular atrophy treated?
There is no treatment. These conditions are slowly or rapidly
progressive, with the exception of German shepherd focal spinal
muscular atrophy where the effects may be relatively mild.
Breeding advice
Affected dogs should not be bred. Breeding of parents and siblings
(suspect carriers) should be avoided as well, so as not to perpetuate
these serious and fortunately rare disorders. In family lines of
Brittany spaniels where this disorder has occurred, dogs should not be
bred until at least 3 years of age to ensure that any carriers are
recognized.
Resources
Ackerman, L. 1999. The Genetic Condition: A Guide to Health Problems in
Purebred Dogs. pp 145-146. AAHA Press. Lakewood, Colorado.
Cummings, J.F., deLahunta, A. 1995. Canine neurodegenerative diseases
involving motor neurons. In J.D. Bonaguara and R.W. Kirk (eds.) Kirk's
Current Veterinary Therapy XII Small Animal Practice. pp. 1132-1136.
W.B.Saunders Co., Toronto.
Cork, L.A. 1992. Canine ventral horn cell disease. In J.D. Bonaguara
and R.W. Kirk (eds.) Kirk's Current Veterinary Therapy XI Small Animal
Practice. pp. 1031-1034. W.B. Saunders Co., Toronto. - This reference
contains information on hereditary canine spinal muscular atrophy in
Brittany spaniels.